ARTICLE | Clinical News
Elafin regulatory update
April 1, 2013 7:00 AM UTC
Proteo said FDA granted Orphan Drug designation for Elafin to prevent inflammatory complications of transthoracic esophagectomy, a surgical procedure for esophageal cancer. Elafin has completed Phase ...